ALPHATEC HOLDINGS, INC. Operating Lease, Expense
ALPHATEC HOLDINGS, INC. (ATEC) reported Operating Lease, Expense of $1.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. operating lease, expense for the quarter ending 2026-06-30 was $1.88M, a 1.05% decline year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, expense for the quarter ending 2026-03-31 was $1.96M, a 7.56% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, expense for the quarter ending 2025-12-31 was $1.97M, a 2.33% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, expense for the quarter ending 2025-09-30 was $1.92M, a 1.99% decline year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, expense for fiscal 2025 was $7.62M, a 3.07% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. operating lease, expense for fiscal 2024 was $7.39M, a 46.54% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. operating lease, expense for fiscal 2023 was $5.04M, a 8.66% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. operating lease, expense for fiscal 2022 was $4.64M, a 3.59% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.88M 10-Q · filed 2026-08-04 | $3.84M 10-Q · filed 2026-08-04 | $5.82M derived: sum of 3 quarters · filed 2026-08-04 | $7.74M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.96M 10-Q · filed 2026-05-05 | $3.94M derived: sum of 2 quarters · filed 2026-05-05 | $5.86M derived: sum of 3 quarters · filed 2026-05-05 | $7.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.89M derived: sum of 2 quarters · filed 2026-02-24 | $5.79M derived: sum of 3 quarters · filed 2026-08-04 | $7.62M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.92M 10-Q · filed 2025-10-30 | $3.82M derived: sum of 2 quarters · filed 2026-08-04 | $5.65M 10-Q · filed 2025-10-30 | $7.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.90M 10-Q · filed 2026-08-04 | $3.73M 10-Q · filed 2026-08-04 | $5.66M derived: sum of 3 quarters · filed 2026-08-04 | $7.61M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.82M 10-Q · filed 2026-05-05 | $3.75M derived: sum of 2 quarters · filed 2026-05-05 | $5.71M derived: sum of 3 quarters · filed 2026-05-05 | $7.75M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.89M derived: sum of 2 quarters · filed 2026-02-24 | $5.93M derived: sum of 3 quarters · filed 2026-02-24 | $7.39M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.96M 10-Q · filed 2025-10-30 | $4.00M derived: sum of 2 quarters · filed 2025-10-30 | $5.46M 10-Q · filed 2025-10-30 | $6.35M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.04M 10-Q · filed 2025-07-31 | $3.50M 10-Q · filed 2025-07-31 | $4.39M derived: sum of 3 quarters · filed 2026-02-24 | $5.99M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.47M 10-Q · filed 2025-05-01 | $2.35M derived: sum of 2 quarters · filed 2026-02-24 | $3.95M derived: sum of 3 quarters · filed 2026-02-24 | $5.27M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.49M derived: sum of 2 quarters · filed 2026-02-24 | $3.80M derived: sum of 3 quarters · filed 2026-02-24 | $5.04M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.60M 10-Q · filed 2024-10-30 | $2.91M derived: sum of 2 quarters · filed 2024-10-30 | $4.16M 10-Q · filed 2024-10-30 | $5.34M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.31M 10-Q · filed 2024-07-31 | $2.56M 10-Q · filed 2024-07-31 | $3.75M derived: sum of 3 quarters · filed 2025-02-26 | $4.96M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.24M 10-Q · filed 2024-05-07 | $2.43M derived: sum of 2 quarters · filed 2025-02-26 | $3.64M derived: sum of 3 quarters · filed 2025-02-26 | $4.73M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.40M derived: sum of 2 quarters · filed 2025-02-26 | $3.49M derived: sum of 3 quarters · filed 2025-02-26 | $4.64M 10-K · filed 2025-02-26 |
| 2022-09-30 | $1.21M 10-Q · filed 2023-11-06 | $2.30M derived: sum of 2 quarters · filed 2023-11-06 | $3.46M 10-Q · filed 2023-11-06 | $4.58M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.09M 10-Q · filed 2023-08-03 | $2.25M 10-Q · filed 2023-08-03 | $3.37M derived: sum of 3 quarters · filed 2024-02-27 | $4.53M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.16M 10-Q · filed 2023-05-04 | $2.28M derived: sum of 2 quarters · filed 2024-02-27 | $3.44M derived: sum of 3 quarters · filed 2024-02-27 | $4.55M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.28M derived: sum of 2 quarters · filed 2024-02-27 | $3.40M derived: sum of 3 quarters · filed 2024-02-27 | $4.48M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.16M 10-Q · filed 2022-11-03 | $2.27M derived: sum of 2 quarters · filed 2022-11-03 | $3.36M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $1.12M 10-Q · filed 2022-08-04 | $2.20M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $1.30M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |